Obermatt

BGM Group

NAQ:BGM · KYG7307E1237
PharmaceuticalsSmall

360° View

no current rank
Price/Sales14
Price/Earnings
Price/Book85
Dividend Yield1
Revenue Growth1
Profit Growth18
Capital Growth67
TSR 52w1
Leverage100
Liquidity6
Refinancing49
Combined
Analyst Opinions
Pro Holdings26
Opinion Changes
Market Pulse31

Profile

CountryBritish Virgin Islands
IndustryPharmaceuticals
SizeSmall
TypePublic Company
ExchangeNASDAQCM
ISINKYG7307E1237
Last UpdateApr 2, 2026
Index & Theme
CardiovascularRespiratoryNutraceuticalFarmingAnimal FeedLivestockChronic DiseasesAlternative Medicine

Description

BGM Group Ltd. (‘BGM’), through its subsidiaries, operates as a pharmaceutical and chemical company in China. BGM’s operations are conducted through contractual arrangements with the Gansu Qilianshan Pharmaceutical Co., Ltd. (the ‘VIE’), based in Ch…

Similar Stocks

The companies this stock is ranked against.

Compare BGM Group with its peers
Aspen Pharmacare
JNB:APN
22
CountrySouth Africa
IndustryPharmaceuticals
SizeLarge
Full Stock Analysis →
T Man Pharmaceutical
SET:TMAN
91
CountryThailand
IndustryPharmaceuticals
SizeSmall
Full Stock Analysis →
Bangkok Lab and Cosmetic
SET:BLC
55
CountryThailand
IndustryPharmaceuticals
SizeSmall
Full Stock Analysis →
Laurus Labs
NSI:LAURUSLABS
28
CountryIndia
IndustryPharmaceuticals
SizeLarge
Full Stock Analysis →
Theravance Biopharma
NMQ:TBPH
87
CountryCayman Islands
IndustryPharmaceuticals
SizeSmall
Full Stock Analysis →
Ultrapar Participacoes
SAO:UGPA3
99
CountryBrazil
IndustrySpecialty Retail
SizeX-Large
Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100
Learn More →